PRESENTATION

Q4 FY2020 — Presentation

Q4 FY2020PDF · 18 pages704 KB
CACI Proprietary Information
CACI International Inc
Q4 and FY20 Earnings Conference Call
August 13, 2020
CACI Proprietary Information

-- 1 of 18 --

2 | CACI Proprietary Information CACI Q4 FY20 Earnings Conference Call
There are statements made herein that do not address historical facts and, therefore, could be interpreted to be forward-
looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. Such statements are subject
to risk factors that could cause actual results to be materially different from anticipated results. These risk factors include, but
are not limited to, the following: our reliance on U.S. government contracts, which includes general risk around the government
contract procurement process (such as bid protest, small business set asides, loss of work due to organizational conflicts of
interest, etc.) and termination risks; significant delays or reductions in appropriations for our programs and broader changes in
U.S. government funding and spending patterns; legislation that amends or changes discretionary spending levels or budget
priorities, such as for homeland security or to address global pandemics like COVID-19; legal, regulatory, and political change
from successive presidential administrations that could result in economic uncertainty; changes in U.S. federal agencies, current
agreements with other nations, foreign events, or any other events which may affect the global economy, including the impact
of global pandemics like COVID-19; the results of government audits and reviews conducted by the Defense Contract Audit
Agency, the Defense Contract Management Agency, or other governmental entities with cognizant oversight; competitive
factors such as pricing pressures and/or competition to hire and retain employees (particularly those with security clearances);
failure to achieve contract awards in connection with re-competes for present business and/or competition for new business;
regional and national economic conditions in the United States and globally, including but not limited to: terrorist activities or
war, changes in interest rates, currency fluctuations, significant fluctuations in the equity markets, and market speculation
regarding our continued independence; our ability to meet contractual performance obligations, including technologically
complex obligations dependent on factors not wholly within our control; limited access to certain facilities required for us to
perform our work, including during a global pandemic like COVID-19; changes in tax law, the interpretation of associated rules
and regulations, or any other events impacting our effective tax rate; changes in technology; the potential impact of the
announcement or consummation of a proposed transaction and our ability to successfully integrate the operations of our
recent and any future acquisitions; our ability to achieve the objectives of near term or long-term business plans; the effects of
health epidemics, pandemics and similar outbreaks may have material adverse effects on our business, financial position, results
of operations and/or cash flows; and other risks described in our Securities and Exchange Commission filings.
Forward-looking Statements

-- 2 of 18 --

3 | CACI Proprietary Information CACI Q4 FY20 Earnings Conference Call
On Today’s Call
John Mengucci
President and Chief
Executive Officer
Thomas Mutryn
Chief Financial Officer
Greg Bradford
President and Chief
Executive, CACI Limited UK

-- 3 of 18 --

4 | CACI Proprietary Information CACI Q4 FY20 Earnings Conference Call
Revenue +15% as reported, +8% organic
Adjusted EBITDA Margin +60 bps to 10.0%1
Diluted EPS +21%
Robust cash flow from operations (>$500 million)1
Record contract awards of $11.6 billion (>55% new business)
NGA TCS award – $1.5 billion over 10 years
DHS CBP BEAGLE award – $1.1 billion over 5 years
Army C5ISR award – $465 million over 5 years
Strong FY20 Performance
1 See slides at the end of this presentation for definitions and reconciliations of non-GAAP measures.

-- 4 of 18 --

5 | CACI Proprietary Information CACI Q4 FY20 Earnings Conference Call
Acquired Ascent Vision Technology (AVT), a leading
Mission Technology provider
Electro-Optical and Infra-Red (EO/IR) imaging technologies
On-board digital video processing using AI and machine learning
Opens two large ISR market growth opportunities
Use of precision sensors to automate platform capabilities
Refresh of existing ISR technology across multiple domains
CACI + AVT = best-in-class Counter-UAS solution
Strong leadership, culture of innovation, best-in-class talent
Expands CACI customer presence with
USAF, USMC, and international customers
Deploying Capital for Growth
5

-- 5 of 18 --

6 | CACI Proprietary Information CACI Q4 FY20 Earnings Conference Call
Total revenue growth of about 7%, 5.5% organic
Adjusted EBITDA Margin1 expansion of 40 basis points
Double-digit EPS growth
Robust cash flow generation
Continued investment in high-demand, high-value capabilities to drive growth
FY21 Guidance Consistent with Financial Goals
1 See slides at the end of this presentation for definitions and reconciliations of non-GAAP measures.

-- 6 of 18 --

7 | CACI Proprietary Information CACI Q4 FY20 Earnings Conference Call
We remain optimistic about CACI’s near- and longer-term prospects
Congress following GFY21 framework established by Budget Control Act of 2019
Actively working to advocate for extension of Section 3610 support
Global threat environment remains elevated
Continue to see bipartisan support for defense and national security priorities
Large and growing addressable market >$230 billion
Budget and Market Environment

-- 7 of 18 --

8 | CACI Proprietary Information CACI Q4 FY20 Earnings Conference Call
Q4 Revenue and Net Income
$50
$94
$0
$20
$40
$60
$80
$100
Q4 FY19 Q4 FY20
Net Income (Ms)
$1,374
$1,496
$800
$1,000
$1,200
$1,400
$1,600
Q4 FY19 Q4 FY20
Revenue (Ms) Revenue driven by new business wins,
on-contract growth, and acquired revenue
Organic growth of 8.1%
COVID-19 negatively impacted Q4 revenue by
$58 million
Higher net income driven by higher revenue
and operating profit, and lower interest
expense, partially offset by higher tax rate
Adjusted EBITDA Margin of 10.9%1
COVID-19 negatively impacted Q4 net
income by $13 million and operating income
by $18 million
+9%
+87%
1 See slides at the end of this presentation for definitions and reconciliations of non-GAAP measures.

-- 8 of 18 --

9 | CACI Proprietary Information CACI Q4 FY20 Earnings Conference Call
FY20 Revenue and Net Income
$266
$321
$0
$50
$100
$150
$200
$250
$300
$350
$400
FY19 FY20
Net Income (Ms)
$4,986
$5,720
$500
$1,500
$2,500
$3,500
$4,500
$5,500
$6,500
FY19 FY20
Revenue (Ms) Revenue driven by new business wins and on-
contract growth, as well as acquired revenue
Organic growth of 8.0% up from 2.8% in FY19
COVID-19 negatively impacted FY20 revenue
by $68 million
Higher net income driven by higher revenue
and operating profit, partially offset by higher
interest expense and tax rate
Adjusted EBITDA Margin of 10.0%1
COVID-19 negatively impacted FY20 net
income by about $18 million and operating
income by $24 million
+15%
+21%
1 See slides at the end of this presentation for definitions and reconciliations of non-GAAP measures.

-- 9 of 18 --

10 | CACI Proprietary Information CACI Q4 FY20 Earnings Conference Call
▪ FY20 net cash provided by operating
activities excluding MARPA of
$511 million1, up 41% year-over-year
▪ Days Sales Outstanding of 57 days1
▪ Leverage of 2.3x2
▪ Strong cash flow and borrowing
capacity provides ample capital for
continued investment and available
liquidity for unforeseen events
Strong Cash Flow
$0
$50
$100
$150
$200
$250
$300
$350
$400
$450
$500
$550
Cash Flow1 and CapEx
(millions, TTM)
Cash Flow from Operations excl. MARPA Capital Expenditures (CapEx)
1 Excludes CACI’s Master Accounts Receivable Purchase Agreement (MARPA); See slides at the end of this presentation for
definitions and reconciliations of non-GAAP measures.
2 Net debt to trailing-twelve-months (TTM) Adjusted EBITDA as of June 30, 2020. Does not include acquisition of AVT.
1

-- 10 of 18 --

11 | CACI Proprietary Information CACI Q4 FY20 Earnings Conference Call
In FY21, AVT expected to add $50 million in revenue and $20 million
in Adjusted EBITDA1 (excluding one-time transaction-related expenses)
Accretive on a GAAP basis, nicely accretive excluding non-cash
intangible amortization and one-time expenses
Purchase price of $350 million, funded by revolving credit facility
Expect to realize tax asset of ~$40 million on a net present value basis
Net of tax asset, paid about 12x NTM Adjusted EBITDA
Leverage of 2.8x2 post closing
AVT Transaction Information
1 See slides at the end of this presentation for definitions and reconciliations of non-GAAP measures
2 Assuming full trailing twelve month (TTM) contribution from AVT acquisition.

-- 11 of 18 --

12 | CACI Proprietary Information CACI Q4 FY20 Earnings Conference Call
FY21 Guidance
FY21 Guidance
Revenue
(millions) $6,000 – $6,200
Net Income
(millions) $347 – $367
Diluted EPS $13.50 – $14.28
Operating Cash Flow1
(millions) At least $580
(1) See slides at the end of this presentation for additional information.
This guidance represents CACI views as of August 12, 2020. Investors are
reminded that actual results may differ from these estimates for reasons
described in the Company’s Safe Harbor Statement and filings with the SEC.
Organic revenue growth of
about 5.5%
Adj. EBITDA Margin of ~10.4%
Diluted shares outstanding
expected to be 25.7 million
Capital expenditures of
~$70 million
Guidance assumes impact of
COVID-19 through Q2 FY21

-- 12 of 18 --

13 | CACI Proprietary Information CACI Q4 FY20 Earnings Conference Call
Depreciation and amortization expected to be ~$130 million
Net interest expense expected to be ~$44 million
Tax rate expected to be ~22% for full year, with lower tax rate in Q2
due to impact of stock award vesting
Expect typical quarterly sequential increase in revenue and profitability
COVID-19 revenue impact of $100 million to $150 million and net income
impact of $20 million to $30 million through December 31, 2020, with
CARES Act Section 3610 support extended through December
FY21 Guidance Assumptions

-- 13 of 18 --

14 | CACI Proprietary Information CACI Q4 FY20 Earnings Conference Call
Positive Forward Indicators for FY21
83%
Existing Business
STRONG
Performance
11%
Recompetes
HIGH
Win Rate
6%
New Business
QUALITY
Pipeline
Record FY20 contract awards of
$11.6 billion
TTM Book-to-Bill of 2.0x
Record backlog of $21.6 billion,
+28% YoY
Pipeline of submitted bids totals
$9.0 billion
>80% for new business to CACI
Bids expected to be submitted in the
next two quarters total $13.7 billion
>70% for new business to CACI

-- 14 of 18 --

15 | CACI Proprietary Information CACI Q4 FY20 Earnings Conference Call
Delivered exceptional financial performance in FY20 while navigating COVID-19
Increased organic revenue growth
Continued margin expansion
Robust cash flow
Record contract awards and backlog
Expect FY21 to be another year of healthy revenue growth, margin expansion,
and robust cash flow
Talented employees committed to delivering expertise and innovative technology
to customers in support of national security and modernization priorities
Confident in our ability to continue to deliver value to customers and shareholders
Delivering Results and Meeting Commitments

-- 15 of 18 --

16 | CACI Proprietary Information CACI Q4 FY20 Earnings Conference Call
The Company defines net cash provided by operating activities excluding CACI’s Master Accounts Receivable Purchase
Agreement (MARPA) as net cash provided by operating activities calculated in accordance with GAAP, adjusted to exclude net
cash received from CACI’s MARPA for the sale of certain designated eligible U.S. government receivables. Under the MARPA,
the Company can sell eligible receivables, including certain billed and unbilled receivables up to a maximum amount of $200.0
million. The Company provides net cash provided by operating activities excluding MARPA to allow investors to more easily
compare current period results to prior period results and to results of our peers.
The Company views Adjusted EBITDA and Adjusted EBITDA margin, both of which are defined as non-GAAP measures, as
important indicators of performance, consistent with the manner in which management measures and forecasts the
Company’s performance. Adjusted EBITDA is a commonly used non-GAAP measure when comparing our results with those of
other companies. We define Adjusted EBITDA as GAAP net income plus net interest expense, income taxes, depreciation and
amortization expense, including depreciation within direct costs, and earnout adjustments. We consider Adjusted EBITDA to
be a useful metric for management and investors to evaluate and compare the ongoing operating performance of our
business on a consistent basis across reporting periods, as it eliminates the effect of non-cash items such as depreciation of
tangible assets, amortization of intangible assets primarily recognized in business combinations, as well as the effect of
earnout gains and losses, which we do not believe are indicative of our core operating performance. Adjusted EBITDA margin
is adjusted EBITDA divided by revenue.
These non-GAAP measures should not be considered in isolation or as a substitute for performance measures prepared in
accordance with GAAP.
Definitions of Non-GAAP Measures

-- 16 of 18 --

17 | CACI Proprietary Information CACI Q4 FY20 Earnings Conference Call
Reconciliation of Net Cash Provided by Operating Activities to Net
Cash Provided by Operating Activities Excluding MARPA
These non-GAAP measures should not be considered in isolation or as a substitute for performance measures prepared in accordance with GAAP.
Quarter
Ended
Quarter
Ended
Twelve
Months Ended
Twelve
Months Ended
(dollars in thousands) 	6/30/2020 	6/30/2019 	6/30/2020 	6/30/2019
Net cash provided by operating activities 	160,880	$ 	102,456	$ 	518,705	$ 	555,297	$
Cash used (provided) by MARPA 	(6,501) 	7,473 	(7,473) 	(192,527)
Net cash provided by operating activities excluding MARPA 	154,379	$ 	109,929	$ 	511,232	$ 	362,770	$

-- 17 of 18 --

18 | CACI Proprietary Information CACI Q4 FY20 Earnings Conference Call
Adjusted Earnings Before Interest, Taxes, Depreciation and
Amortization (Adjusted EBITDA)
These non-GAAP measures should not be considered in isolation or as a substitute for performance measures prepared in accordance with GAAP.
(dollars in thousands) 	6/30/2020 	6/30/2019 % Change 	6/30/2020 	6/30/2019 % Change
Net income 	93,731	$ 	50,030	$ 	87.3% 	321,480	$ 	265,604	$ 	21.0%
Plus:
Income taxes 	29,498 	12,881 	129.0% 	80,157 	62,305 	28.7%
Interest income and expense, net 	10,447 	18,185 	-42.6% 	56,059 	49,958 	12.2%
Depreciation and amortization expense,
including depreciation within direct costs
29,264 	27,691 	5.7% 	112,889 	88,603 	27.4%
Earnout adjustments 	- 	700 	-100.0% 	3,000 	1,000 	200.0%
Adjusted EBITDA 	162,940	$ 	109,487	$ 	48.8% 	573,585	$ 	467,470	$ 	22.7%
(dollars in thousands) 	6/30/2020 	6/30/2019 % Change 	6/30/2020 	6/30/2019 % Change
Revenue, as reported 	1,495,581	$ 	1,373,878	$ 	8.9% 	5,720,042	$ 	4,986,341	$ 	14.7%
Adjusted EBITDA 	162,940 	109,487 	48.8% 	573,585 	467,470 	22.7%
Adjusted EBITDA margin 	10.9% 	8.0% 	10.0% 	9.4%
Quarter Ended 	Twelve Months Ended
Quarter Ended 	Twelve Months Ended

-- 18 of 18 --